WBB Securities acted as the sole placement agent for a $9 million Series A funding round for FELIQS
WBB Securities today announced it had acted as the sole placement agent for a $9 million Series A funding round for FELIQS, a biotechnology company developing first-in-class small molecule therapeutics for rare pediatric retinal diseases.
Read More about WBB Securities acted as the sole placement agent for a $9 million Series A funding round for FELIQS